PAO Group, Inc.

Recent News

  • PAOG Advances Nutraceutical Development From Its Cannabis Pharmaceutical Research

    Sandusky, Ohio--(Newsfile Corp. - October 29, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced adding a nutraceutical development pathway to its existing pharmaceutical cannabis drug development strategy. Last week, PAOG announced a master services agreement with a clinical research organization (CRO) in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA). More details on the CRO contract are coming soon. Now PAOG has committed...

    2020-10-29 1:16 PM ET
  • PAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory Approval

    Sandusky, Ohio--(Newsfile Corp. - October 23, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced executing a master services agreement with a clinical research organization in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG signed the agreement yesterday, prior to the comprehensive corporate update scheduled for publication today and included in its entirety below.Corporate UpdateLess than 90 days ago, PAOG acquired RespRx from Kali-Extracts,...

    2020-10-23 9:20 AM ET
  • PAOG Advances FDA Application Process For Respiratory Cannabis Drug Treatment

    Sandusky, Ohio--(Newsfile Corp. - October 20, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced that the company plans to release a new key update this Friday, October 23, 2020, on its progress to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG announced last week that it soon anticipates to enter into an agreement with a contract research organization (CRO) making a major breakthrough in advancing PAOG's RespRx treatment for...

    2020-10-20 9:18 AM ET
  • PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness

    Sandusky, Ohio--(Newsfile Corp. - October 16, 2020) - PAO Group, Inc. (OTC Pink: PAOG) and Puration, Inc. (OTC Pink: PURA) today announced a free hemp seed giveaway in conjunction with the recent partnership between the two companies where PAOG will be building a hemp cultivation facility on PURA's Farmersville, Texas property. HEMPTo view an enhance

    2020-10-16 1:17 PM ET
  • PAOG Releases Cannabis Drug Development Update

    Sandusky, Ohio--(Newsfile Corp. - October 15, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today published a progress update on the company's ongoing initiative to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG anticipates entering into an agreement with a contract research organization (CRO) within the next two weeks. The CRO engagement will be a major breakthrough in advancing PAOG's RespRx treatment for Chronic Obstructive Pulmonary Disease (COPD) toward FDA approval.On...

    2020-10-15 9:10 AM ET
  • PAOG Targets Spring Launch of Hemp Cultivar Facility

    Sandusky, Ohio--(Newsfile Corp. - October 13, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed an agreement with Puration, Inc. (OTC Pink: PURA) to build a proprietary hemp cultivar development facility on PURA's Farmersville, Texas branded site and announced an April 2021 target date for construction to be completed.PAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the company's overall pharmaceutical focus.PAOG...

    2020-10-13 9:09 AM ET
  • PAOG CEO Jim DiPrima Answers Questions About Cannabis Investigational New Drug Application Plans with FDA

    Sandusky, Ohio--(Newsfile Corp. - October 2, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses recent news regarding PAOG's latest moves to engage a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA).MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing...

    2020-10-02 10:01 AM ET
  • PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND

    Sandusky, Ohio--(Newsfile Corp. - October 1, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced engaging Saul Kaye, the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide an independent review of PAOG's RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RespRx for engaging with a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA).Saul is a licensed pharmacist an

    2020-10-01 10:08 AM ET